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Acetylation of general transcription factors by histone
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The acetylation of histones increases the accessibility of
nucleosomal DNA to transcription factors [1,2], relieving
transcriptional repression [3] and correlating with the
potential for transcriptional activity in vivo [4–7]. The
characterization of several novel histone
acetyltransferases — including the human GCN5
homolog PCAF (p300/CBP-associated factor) [8], the
transcription coactivator p300/CBP [9], and TAFII250 [10]
— has provided a potential explanation for the
relationship between histone acetylation and
transcriptional activation. In addition to histones,
however, other components of the basal transcription
machinery might be acetylated by these enzymes and
directly affect transcription. Here, we examine the
acetylation of the basal transcriptional machinery for
RNA polymerase II by PCAF, p300 and TAFII250. We find
that all three acetyltransferases can direct the
acetylation of TFIIEb and TFIIF, and we identify a
preferred site of acetylation in TFIIEb. Human TFIIE
consists of two subunits, a (p56) and b (p34), which form
a heterotetramer (a2b2) in solution ([11], reviewed in
[12]). TFIIE enters the preinitiation complex after RNA
polymerase II and TFIIF, suggesting that TFIIE may
interact directly with RNA polymerase II and/or TFIIF
[13,14]. In addition, TFIIE can facilitate promoter melting
either in the presence or absence of TFIIH and can
stimulate TFIIH-dependent phosphorylation of the
carboxy-terminal domain of RNA polymerase II [15–18].
TFIIF has an essential role in both transcription initiation
and elongation ([19,20], for review see [21]). We discuss
the implications of the acetylation of TFIIEb and TFIIF for
transcriptional control by PCAF, p300 and TAFII250.
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Results and discussion
To ascertain whether any transcription factors can be tar-
geted by histone acetyltransferases, we first normalised
the amount of each factor studied both by Coomassie blue
staining after SDS-polyacrylamide gel electrophoresis
(PAGE; Figure 1a) and by the Bradford method. The
recombinant transcription factors studied were TFIIA
(p55 and p12 subunits), TFIIB, TATA-binding protein
(TBP), the α and β subunits of TFIIE, TFIIF (RAP30
and RAP74 subunits), and the core histones H3 and H4.
Each  transcription factor was incubated with recombinant
PCAF, p300 or TAFII250 in the presence of [3H]acetyl
CoA (Figure 1b–d). The various acetyltransferases showed
substrate selectivity in that histones H3 and H4 were
acetylated by all three acetyltransferases, but H4 was
modified more efficiently by p300 than by PCAF or
TAFII250 (Figure 1d). The β subunit of TFIIE was also
acetylated by all three enzymes (Figure 1b–d, lane 3).
Both subunits of TFIIF, RAP74 and RAP30, were acety-
lated by PCAF and p300 (Figure 1b,c, lane 2), but
TAFII250 had little effect on this factor (Figure 1d, lane
2). These observations demonstrate that histone acetyl-
transferases PCAF and p300 acetylate not only histones
H3 and H4 but also the general transcription factors
TFIIEβ and TFIIF.
In order to quantify more accurately the efficiency of
acetylation of TFIIEβ in comparison to histones H3 and
H4, we varied the amounts of substrate proteins while
keeping the amount of acetyl CoA constant (Figure 1e–g).
Quantification of acetyl CoA incorporation into each sub-
strate under saturating conditions revealed that TFIIEβ is
a comparable substrate to histones H3 and H4 for both
PCAF and p300 (Table 1). TAFII250 shows, however,
reduced activity for all tested substrates. The incorpora-
tion of acetyl CoA into TFIIEβ catalyzed by PCAF under
the saturating conditions ([TFIIEβ] / [acetyl CoA] = 0.5)
was 23%, which correlates to 46% of the molecules acety-
lated if TFIIEβ has one acetylation site (see Figure 2).
To ensure that the acetylation of histones H3 and H4 and
TFIIEβ requires enzymatic catalysis and does not result
from noncovalent binding, we tested their acetylation by
full-length PCAF, by an amino-terminal, non-catalytic
PCAF fragment, by the carboxy-terminal PCAF acetyl-
transferase domain (Figure 2a) and by recombinant yeast
HAT1 [22] in a standard acetylation assay. As shown in
Figure 2b, wild-type PCAF and the carboxy-terminal
acetyltransferase domain fragment acetylated the core his-
tones (lanes 1,3) and TFIIEβ (lanes 6,8), whereas yeast
HAT1 acetylated H4 only (lane 4). Under identical condi-
tions, no signal was detected in the reactions containing
the non-catalytic, amino-terminal fragment of PCAF
(lanes 2,7) or the control containing no enzyme (lanes
5,10). These results confirm that acetylation of TFIIEβ
requires enzymatic function and does not result from non-
covalent binding of acetyl CoA to TFIIEβ. It is also appar-
ent that considerable specificity exists in substrate
utilization by the different acetyltransferases.
Recently, Kuo et al. [23] showed that yGCN5p — a yeast
homolog of the human PCAF protein — acetylates
histone H3 specifically at lysine 14. A comparison of the
sequences of human TFIIEβ and human H3 suggested
that the lysine at position 52 in TFIIEβ was a candidate
for acetylation by PCAF. This sequence is conserved
among human, Xenopus and yeast TFIIEβs, implying a
functional significance (Figure 2c). We mutated human
TFIIEb Lys 52 to arginine and compared it with wild-
type TFIIEb as a substrate for acetylation. We found that
acetylation of the mutant form by PCAF or p300 of
TFIIE was severely reduced (more than 90%) compared
with wild-type (Figure 2d, compare lanes 1–3 with 4–6,
and 7–9 with 10–12). 
Our experiments indicate that TFIIE and TFIIF are sub-
strates for acetylation by the acetyltransferases PCAF and
p300 (Figures 1,2). Using standard in vitro assays, experi-
ments examining the functional role for acetylation of
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Histone acetyltransferases selectively acetylate general transcription
factors. Core histones and purified recombinant general transcription
factors for RNA polymerase II were normalized by SDS PAGE and
visualized by Coomassie blue staining (a), or acetylated in the
presence of [3H]acetyl CoA by PCAF (b), by p300/CBP (c) or by
TAFII250 (d). Lane 1: core histones; lane 2: RAP74 and RAP30
subunits of TFIIF; lane 3: TFIIEβ (p34); lane 4: TFIIEα (p56); lane 5:
TBP; lane 6: TFIIB; lane 7: TFIIA (p55 and p12). Protein molecular
weight standards in kilodaltons (kDa) are indicated on the right. The
smaller peptide (~28 kDa) detected in the TBP fraction is an E. coli
protein copurified from nickel agarose column. Core histones were a
gift from A. Gegonne; recombinant general transcription factors and
histone acetyltransferases were expressed and purified as described
[8–10,23]. Concentrations of each factor were determined by both
Bradford method and SDS-PAGE. In vitro acetylation assays (20 nl)
were carried out with 100 ng of acetyltransferase, 1 ng of substrate,
43 pmol of [3H]acetyl CoA (5.8 Ci/mmol, Amersham Life Science),
10 mM sodium butyrate in the HAT buffer [50 mM Tris-Cl (pH 8.0),
10% glycerol, 1 mM DTT, 1 mM PMSF] at 37°C for 30 min [27].
Reactions were stopped by adding 10 nl of 3× Laemmli buffer and
analyzed on an 18% SDS PAA gel. Gels were stained with Coomassie
blue, destained, treated with Amplify (Amersham Life Science) for
15 min and exposed for 2–5 days. (e–g) Quantification of acetylation.
Increasing amounts of TFIIEβ (open triangles), histone H3 (solid
circles) and H4 (solid squares) were incubated with a fixed amount of
acetyl CoA (43 pmol) in the presence of 100 ng PCAF (e), p300 (f), or
TAFII250 (g). Corresponding signals are indicated on the left. 
Table 1
Incorporation of acetyl CoA into substrate proteins.
Substrate incorporation (%)
Enzyme RAP74 RAP30 TFIIEβ H3 H4
PCAF 8 ± 2.8 3 ± 0.8 23 ± 4.5 30 ± 3.0 15 ± 3.2
p300 22 ± 3.7 8 ± 2.8 8 ± 2.8 8 ± 2.8 20 ± 1.5
TAFII250 ND ND 6 ± 3.0 8 ± 1.8 4 ± 0.8
Determination of pmol of acetyl CoA incorporated into the substrate
proteins at saturation levels. Percentages of total input acetyl CoA
incorporated into the proteins are indicated (errors represent the
variation on three independent determinations). ND, not detectable.
TFIIE and/or TFIIF on various promoters have so far
failed to reveal transcriptional stimulation due to acetylation
([24] and data not shown). However, other transcriptional
activators or templates such as those assembled into chro-
matin may be more sensitive to acetylation of the general
transcriptional machinery. Our results suggest that PCAF,
p300/CBP and TAFII250 will have the capacity to modify
many other components of the transcriptional regulatory
machinery aside from the histones.
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The effect of various domains of PCAF on the acetylation of TFIIEβ. 
(a) The amino-terminal and carboxy-terminal domains of PCAF used in
these experiments. (b) Core histones (lanes 1–5) and TFIIEβ (lanes
6–10) were used as substrates in a standard acetylation assay (see
legend to Figure 1). The position of TFIIEβ, H3 and H4 and
autoacetylated PCAF (asterisk) is indicated. The various proteins
tested for acetyltransferase activity are indicated above the gel lanes.
Human PCAF (hPCAF), amino-terminal (N-term) and carboxy-terminal
(C-term) fragments of hPCAF and yeast histone acetyltransferase 1
(yHAT1) were used. (c) Mutation of the major site of acetylation in
TFIIEβ. Alignment of TFIIEβ proteins from human (hTFIIEβ), Xenopus
(xTFIIEβ) and yeast (yTFIIEβ) and human histone H3 (hH3). The
asterisk indicates the conserved lysine 52 in human TFIIEβ that was
mutated to an arginine by amplifying the 5′ end of the TFIIEβ cDNA
with primers IIE5′ (GCG GAT CCC TGT TGA GAG AAA GGG AG)
and K52Rrev (GAT CAG AAT TTT GTC TAG AGC CTG ACG ATCC)
and the 3′ end with primers IIE3′ (GCC TCG AGC TAT TTG CTG
GAA GTA ATG TC) and K52R (GGA TCG TCA GGC TCT AGA CAA
AAT TCT GATC). PCR reactions were then purified and fused
together by another amplification step using only primers IIE5′ and
IIE3′. The completed PCR reaction was cloned into the BamHI and
XhoI sites of the bacterial expression vector pRSETA (Invitrogen, San
Diego). Recombinant TFIIEβ K52R was expressed in E. coli and
purified by Ni-column chromatography [24]. (d) PCAF and p300 were
used in the standard acetylation assay [25] to examine the acetylation
of wild-type TFIIEβ (wt) and mutant TFIIEβ (K52R). The mutant
migrates slightly differently in SDS gels because of a short amino-
terminal extension.
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